Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 765 results for "glenmark"

Buy Glenmark Pharma Ltd with a target of Rs 845: Ashwani Gujral

In a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com, shares his views on . ET Now: What is your call on ? Ashwani Gujral: is a 'BUY' call with a target of Rs 845 and a stop loss of Economic Times, 1 day ago

75 images for glenmark

Drug Discovery and Development, 1 week ago
ABC News 4 Charleston, 1 week ago
I Stock Analyst, 1 week ago
Sys-Con Media, 1 week ago
PR Newswire, 1 week ago
Livemint.com, 1 month ago
Bioresearch Online, 1 month ago
Pharma Letter, 2 months ago
Livemint.com, 2 months ago
NDTV, 2 months ago
Money Control

Top10: Stocks to focus on September 29

Here are Top 10 stocks to focus on September 29 - Bank Nifty, Infosys, Glenmark Pharma, Valecha Engineering, Mayur Uniquoters, Anant Raj Industries, MTNL, Reliance Power, Patel Logistics And Ajanta Pharma
 Money Control2 days ago Stocks in news: Wipro, SKS, Ambuja, Ranbaxy, JSW Energy  Money Control2 months ago Here are top 10 stocks to focus on July 25  Money Control2 months ago Top 10 stocks to focus on July 4  Money Control2 months ago

Prefer DCB Bank, Glenmark Pharma: Sandeep Bhatia

Sandeep Bhatia, Executive Director Head of Sales at Kotak Institutional Equities is of the view that one may prefer Glenmark Pharma and DCB Bank.
 Money Control1 week ago Pharma sector could trend in second half: Kotak  Moneycontrol.com1 week ago Prefer HDFC Bank, ICICI Bank, TCS, Lupin: Jeff Chowdhry  Money Control2 months ago

Glenmark's TRPA1 antagonist shows positive data in a proof of concept study

TRPA1 is an ion channel expressed on peripheral and spinal sensory neurons and it mediates pain signal transmission Glenmark Pharmaceuticals' first in class Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 has shown positive ...
 Express Pharma2 weeks ago Glenmark's GRC 17536 shown positive data in phase 2a study in patients with painful diabetic neuropathy  PharmaBiz2 weeks ago Glenmark Pharma - Glenmark's TRPA1 antagonist GRC 17536 sh...  SBICAP Securities2 weeks ago Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study  Red Orbit1 week ago
[x]  

Buy Glenmark Pharma: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that one can buy Glenmark Pharma.
 Money Control1 week ago Get in Glenmark Pharma, says Sukhani  Money Control4 weeks ago Buy Dabur, Glenmark Pharma, HCL Tech: Sudarshan Sukhani  Money Control1 month ago

14 stocks which can become multi-baggers in next 3-5 years

Stocks such as Mindtree, Bajaj Auto, Havells, SKS Micro Finance, Sintex, Glenmark, Jyothy Lab and Sun Pharma are gems and can grow by 15 per cent compounded over the next 3-5 years, says Dipan Mehta, Member, BSE and NSE, in an exclusive interview ...
 Economic Times2 weeks ago
Bioresearch Online

Glenmark Pharmaceuticals initiates IND enabling studies for cancer treatment

Glenmark Pharmaceuticals S.A., a manufacturer of generic pharmaceutical products, has initiated the IND enabling studies of a new clinical development candidate, GBR 1302, a HER2xCD3 bispecific antibody, for the treatment of cancer. GBR 1302 was ...
 Individual.com3 weeks ago Glenmark discovers new molecule; enters oncology segment  Business Standard1 month ago Glenmark Pharma at new high, up 4% on foray into oncology  Money Control1 month ago Glenmark enters oncology segment with discovery of GBR 1302  Money Control1 month ago
[x]  

Biocon, Glenmark Pharma, Arvind to get astro support: Gupta

According to Satish Gupta of astrostocktips.in, pharma stocks like Biocon, Glenmark Pharma, Aurobindo Pharma, Divis Laboratories and Cipla will be getting astro support.
 Money Control3 weeks ago Cipla, TCS, Ranbaxy, Polaris to get astro support: Gupta  Money Control1 month ago Infosys, TCS, Cipla, Divis Labs to get astro support: Gupta  Moneycontrol.com5 days ago BHEL, Crompton, Arvind, Biocon to get astro support: Gupta  Moneycontrol.com1 week ago

Dr Reddy's, Lupin, BOI, SBI to get astro support: Gupta

Pharma stocks like Glenmark Pharma, Divis Laboratories, Dr Reddy's Laboratories, Lupin and Biocon will be getting astro suppport, says Satish Gupta of astrostocktips.in.
 Money Control2 weeks ago Dr Reddy's, Glenmark, Ranbaxy to get astro support: Gupta  Money Control2 months ago TCS, Infosys, ACC, Dr Reddy's to get astro support: Gupta  Moneycontrol.com1 month ago Lupin, Dr Reddys Lab top picks in pharma space: ICICIdirect  Money Control2 months ago

Buy Glenmark with a target of 815: Mitesh Thacker

In a chat with ET Now, Mitesh Thacker, Technical Analyst, miteshthacker.com, shares his views on markets. Excerpts: ET NOW: What is your take on Glenmark? Mitesh Thacker: Glenmark is a buy with a stop below 770 for targets
 Economic Times2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less